State Board Of Administration Of Florida Retirement System Inhibrx, Inc. Transaction History

State Board Of Administration Of Florida Retirement System

$51.5 Billion
Q3 2024

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$14.5 - $38.0 $142,361 - $373,084	9,818 New	9,818 $373,000
Q2 2023 Aug 11, 2023	BUY	$16.96 - $27.82 $165,326 - $271,189	9,748 New	9,748 $253,000
Q4 2022 Jun 14, 2023	BUY	$20.18 - $33.33 $193,284 - $319,234	9,578 New	9,578 $236,000
Q4 2022 Feb 07, 2023	SELL	$20.18 - $33.33 $22,399 - $36,996	-1,110 Reduced 10.39%	9,578 $236,000
Q2 2022 Aug 05, 2022	BUY	$8.52 - $25.26 $91,061 - $269,978	10,688 New	10,688 $121,000
Q1 2022 May 06, 2022	SELL	$19.89 - $43.18 $124,670 - $270,652	-6,268 Closed	0 $0
Q4 2021 Feb 08, 2022	BUY	$26.75 - $46.02 $3,664 - $6,304	137 Added 2.23%	6,268 $274,000
Q3 2021 Nov 08, 2021	BUY	$25.18 - $37.81 $154,378 - $231,813	6,131 New	6,131 $204,000

Others Institutions Holding INBX

# of Institutions

Shares Held

18.6K

Call Options Held

Put Options Held

Credit Suisse Ag Zurich, V8

18.6K
Shares

$268,577
0.0% of portfolio

View Full List

About Inhibrx, Inc.

Ticker INBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,057,700
Market Cap $565M
Description
Inhibrx, Inc., a clinical-stage biotechnology company, focuses on developing a pipeline of novel biologic therapeutic candidates. The company's therapeutic candidates include INBRX-109, a tetravalent agonist of death receptor 5, which is in Phase 2 clinical trials to treat cancers, such as chondrosarcoma, mesothelioma, and pancreatic adenocarcin...

More about INBX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Board Of Administration Of Florida Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on State Board Of Administration Of Florida Retirement System with notifications on news.

Account